Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3 million collaborative UKRI-funded project as part of the medicines manufacturing challenge. Symbiosis and The Cell and Gene Therapy Catapult (CGT Catapult) […]

The post Symbiosis announces successful completion of UKRI project, which will enhance the manufacturing supply chain for ATMPs within the UK first appeared on World Pharma Today.